SCA
MBIO icon

Sassicaia Capital Advisers’s Mustang Bio MBIO Stock Holding History

Sassicaia Capital Advisers’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-28
Closed -$8.29K – 43
2022
Q4 		$8.29K Buy
28
+3
+12% +$1.02K 0.02% 27
2022
Q3 		$9K Buy
25
+3
+14% +$1.39K 0.33% 5
2022
Q2 		$10K Buy
22
+6
+38% +$3.32K 0.06% 15
2022
Q1 		$12K Sell
16
-5
-24% -$4.11K 0.06% 21
2021
Q4 		$26K Buy
+21
New +$33.9K 0.18% 18
2021
Q3 		– Sell
-24
Closed -$60K – 55
2021
Q2 		$60K Buy
+24
New +$58.8K 0.06% 36
2021
Q1 		– Sell
-15
Closed -$43K – 76
2020
Q4 		$43K Buy
+15
New +$35.9K 0.09% 31

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sassicaia Capital Advisers's MBIO Position: Q1 2023 in Review

Sassicaia Capital Advisers sold out of Mustang Bio (MBIO) in Q1 2023, closing a stake of 28 shares — an estimated $8.29K sold.

Sassicaia Capital Advisers first reported a position in MBIO in Q4 2020 and held it in 7 quarters. The position peaked at $60K in Q2 2021. 48 funds tracked by Wall St. Rank hold MBIO as of Q1 2023.

  • Sassicaia Capital Advisers reported no remaining Mustang Bio position as of Q1 2023 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 28 Mustang Bio shares in Q1 2023, an estimated $8.29K.
  • Sassicaia Capital Advisers first reported a position in Mustang Bio in Q4 2020 and held it in 7 quarters.
  • Sassicaia Capital Advisers's Mustang Bio position peaked at $60K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2023.

Based on Sassicaia Capital Advisers's 13F filing for Q1 2023, filed 15 May 2023.